Targeting GPCRs to treat cardiac fibrosis

Cardiac fibrosis occurs ubiquitously in ischemic heart failure, genetic cardiomyopathies, diabetes mellitus, and aging. It triggers myocardial stiffness, which impairs cardiac function, ultimately progressing to end-stage heart failure and increased mortality. Although several targets for anti-fibro...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hao, Ren, Lu, Shivnaraine, Rabindra Vishwadev
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582444/
https://www.ncbi.nlm.nih.gov/pubmed/36277752
http://dx.doi.org/10.3389/fcvm.2022.1011176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582444/
https://www.ncbi.nlm.nih.gov/pubmed/36277752
http://dx.doi.org/10.3389/fcvm.2022.1011176

Ejemplares similares